Related references
Note: Only part of the references are listed.Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
Lorraine Harper et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
Michael Walsh et al.
ARTHRITIS AND RHEUMATISM (2012)
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Kirsten de Groot et al.
ANNALS OF INTERNAL MEDICINE (2009)
Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis - A 12-year single-practice experience
Alexandra Villa-Forte et al.
MEDICINE (2007)
Predictors of relapse and treatment resistance in antineutrophil cytoplasmic anti body-associated small-vessel vasculitis
SL Hogan et al.
ANNALS OF INTERNAL MEDICINE (2005)
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
K de Groot et al.
ARTHRITIS AND RHEUMATISM (2005)
Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis
I Neumann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
D Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study
AD Booth et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Share Paper
